MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2024 International Congress

    A group of patients with multiple system atrophy (MSA) exhibit cardiac sympathetic dysfunction to the same extent as Parkinson’s disease (PD).

    R. Yokoyama, T. Yamamoto (Moroyama, Japan)

    Objective: Although there are cases of multiple system atrophy (MSA) with decreased MIBG, there has not been sufficient investigation into the proportion. Thus, we retrospectively…
  • 2024 International Congress

    Analysis of structural connectivity in relation to change in dopaminergic medication after 6 months of STN-DBS in Parkinson´s disease – a pilot study

    š. Janovič, D. Kroneberg, B. Al-Fatly, A. Kušnírová, Z. Košutzká (Bratislava, Slovakia)

    Objective: To describe the relationship between structural connectivity and it´s effect on change in levodopa equivalent daily dose (LEDD) in patients 6 months after subthalamic…
  • 2024 International Congress

    Abnormal basal ganglia-related functional gradient in Parkinson’s disease

    L. Chen, L. Sun, M. Xia, T. Wu (Beijing, China)

    Objective: The aim of this research was to investigate the basal ganglia (BG)-related functional gradient alterations and the association between these brain dysfunctions and clinical…
  • 2024 International Congress

    Impact of Altered Cerebrovascular Reactivity on Midbrain Degeneration, Perfusion and White Matter

    N. Hoffman, S. Nitschke, K. Julio, N. Shaff, A. Dodd, G. Suarez Cedeno, A. Deligtisch, D. Sugar, E. Erhardt, H. Lin, A. Vakhtin, H. Van-Der-Horn, S. Pirio Richardson, A. Mayer, S. Ryman (Albuquerque, USA)

    Objective: To evaluate whether altered cerebrovascular reactivity contributes to midbrain degeneration, perfusion abnormalities, or white matter disease in patients with Parkinson’s disease (PD). Background: Cerebrovascular…
  • 2024 International Congress

    Improved Quantification of DAT-SPECT significantly increases its Performance as an Imaging Biomarker in Parkinson’s Disease

    R. Gunn, Z. Fan, D. Russell, J. Eberling, K. Marek, J. Seibyl, FOR. Ppmi (London, United Kingdom)

    Objective: To investigate potential improvements in signal-to-noise (SNR) derived from advanced image analysis of longitudinal DAT-SPECT data. Background: [123I]Ioflupane SPECT (DAT-SPECT) has been widely used…
  • 2024 International Congress

    Transcranial Sonography of the Substantia Nigra and Vagus Nerve Ultrasonography as Complementary Diagnosis for Parkinson’s Disease.

    W. Quaresma, G. Castro, E. Santos, A. Felicio, J. Duarte, B. Gomes, B. Santos-Lobato, J. Quaresma, L. Krejcová (Sao Paulo, Brazil)

    Objective: We aim to investigate the relationship between sonographic abnormalities of the substantia nigra, vagus nerve cross-sectional area and clinical features of PD in different…
  • 2024 International Congress

    Early changes in the locus coeruleus in mild cognitive impairment with Lewy bodies

    I. Rektorova, Z. Zeleznikova, L. Brabenec, K. Mitterova, L. Novakova (Brno, Czech Republic)

    Objective: To evaluate NMS signal changes in the locus coeruleus (LC) in mild cognitive impairment with Lewy bodies (MCI-LB) as compared to healthy controls (HC)…
  • 2024 International Congress

    Safety of staged bilateral MR-guided focused ultrasound thalamotomy for essential tremor

    M. Kaplitt, H. Sarva, V. Krishna, HM. Eisenberg, WJ. Elias, P. Ghanouni, GH. Baltuch, A. Rezai, C. Halpern, B. Dalm, P. Fishman, V. Buch, S. Moosa, AM. Murray (New York, USA)

    Objective: To evaluate the efficacy and safety of staged bilateral magnetic resonance-guided focused ultrasound (MRgFUS) thalamotomy in patients with medication-refractory bilateral essential tremor (ET). Herein,…
  • 2024 International Congress

    Vim DBS for Post-Stroke Tremor: A Case Report

    R. Lowe, S. Ikramuddin, M. Johnson, N. Harel, T. Palnitkar, R. Patriat, J. Vitek, L. Almeida (, Minneapolis, USA)

    Objective: We report a unique case of post-stroke tremor (PST) with a robust response to deep brain stimulation (DBS) of the ventral intermediate nucleus of…
  • 2024 International Congress

    Evoked Resonant Neural Activity Automates Field Shaping of Subthalamic Nucleus-Deep Brain Stimulation in Parkinson’s Disease

    K. Nagao, T. Perera, M. Petoe, W-L. Lee, S. Xu, K. Lawson, A. Moorhead, H. Mcdermott, W. Thevathasan (East Melbourne, Australia)

    Objective: Compare motor efficacy and tolerability of 3 methods to guide electrical field shaping of subthalamic nucleus (STN) deep brain stimulation (DBS) in Parkinsons disease…
  • « Previous Page
  • 1
  • …
  • 106
  • 107
  • 108
  • 109
  • 110
  • …
  • 181
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • #23285 (not found)
  • The hardest symptoms that bother patients with Parkinson's disease
  • Life expectancy with and without Parkinson’s disease in the general population
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • Patients with Essential Tremor Live Longer than their Relatives
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley